Choudhury, A. D., Ballman, K. V., Reimers, M. A., Laccetti, A. L., Smieliauskas, F., Ravi, P., Xiao, H., Dooley, K., Hillman, D. W., Mazza, G. L., Gartrell, B., Steen, P. D., Smith, T. J., Beltran, H., Chen, R. C., Berg, S. A., McKay, R. R., Galsky, M. D., Rosenberg, J. E., Morris, M. J. (2026). A phase 2 trial of androgen deprivation therapy interruption in patients responding exceptionally to androgen receptor pathway inhibitor in metastatic hormone-sensitive prostate cancer (A-DREAM / Alliance A032101).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5004